Nuwellis (NUWE) FCF Margin Growth (5y) (2018 - 2026)
Nuwellis (NUWE) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,277.00 |
| Dec 31, 2025 | 4,673.00 |
| Sep 30, 2025 | 9,213.00 |
| Jun 30, 2025 | 5,625.00 |
| Mar 31, 2025 | 20,497.00 |
| Dec 31, 2024 | 23,095.00 |
| Sep 30, 2024 | 19,732.00 |
| Jun 30, 2024 | 11,691.00 |
| Mar 31, 2024 | 25,156.00 |
| Dec 31, 2023 | 7,611.00 |
| Sep 30, 2023 | 8,739.00 |
| Jun 30, 2023 | 6,345.00 |
| Mar 31, 2023 | 15,602.00 |
| Dec 31, 2022 | 25,106.00 |
| Sep 30, 2022 | 18,155.00 |
| Jun 30, 2022 | 29,655.00 |
| Mar 31, 2022 | -7,512.00 |
| Dec 31, 2021 | 6,361.00 |
| Sep 30, 2021 | 65,168.00 |
| Mar 31, 2020 | 1.19 Mn |